Literature DB >> 10194775

No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study.

P Falkai1, W G Honer, S David, B Bogerts, C Majtenyi, T A Bayer.   

Abstract

Schizophrenia is clinically and neuropsychologically characterized by severe cognitive and functional impairment suggesting the presence of a neurodegenerative process in the brains of affected individuals. A variety of neuroanatomical changes have been described such as loss and disorientation of neurons in grey and white matter and cortical atrophy. However, the neuropathological basis for schizophrenia is still unclear. In the present study we monitored the density of GFAP-positive astrocytes in brains of 33 schizophrenic patients and 26 healthy controls. Both grey matter (entorhinal cortex and subiculum) and white matter (premotor cortex, subventricular zone of the third ventricle and next to inferior horn) structures were measured bilaterally. The overall finding was that there is no evidence for increased astrogliosis in brains of schizophrenic patients vs healthy controls. Therefore, degeneration is unlikely to be the main neuropathological mechanism in schizophrenic brains.

Entities:  

Mesh:

Year:  1999        PMID: 10194775     DOI: 10.1046/j.1365-2990.1999.00162.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  24 in total

1.  Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia.

Authors:  Matthew Roy Williams; Thomas Hampton; Ronald K B Pearce; Steven Richard Hirsch; Olaf Ansorge; Maria Thom; Michael Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06-04       Impact factor: 5.270

Review 2.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 3.  Searching for neuropathology: gliosis in schizophrenia.

Authors:  Tatiana P Schnieder; Andrew J Dwork
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

Review 4.  [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts].

Authors:  P Falkai; W Maier
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

5.  Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model.

Authors:  John P Kim; Margaret R Lentz; Susan V Westmoreland; Jane B Greco; Eva M Ratai; Elkan Halpern; Andrew A Lackner; Eliezer Masliah; R Gilberto González
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

6.  Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.

Authors:  J Steiner; H Bielau; H-G Bernstein; B Bogerts; M T Wunderlich
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11       Impact factor: 10.154

Review 7.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  Neuropathological changes in the nucleus basalis in schizophrenia.

Authors:  M R Williams; R Marsh; C D Macdonald; J Jain; R K B Pearce; S R Hirsch; O Ansorge; S M Gentleman; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-12-11       Impact factor: 5.270

9.  Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder.

Authors:  Christa Hercher; Vikramjit Chopra; Clare L Beasley
Journal:  J Psychiatry Neurosci       Date:  2014-11       Impact factor: 6.186

10.  Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia.

Authors:  Clare L Beasley; Andrew J Dwork; Gorazd Rosoklija; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasa Davceva; Andrew R Tait; Suzana K Straus; William G Honer
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.